ヒュミラ医薬品の世界市場レポート 2024

ヒュミラ医薬品の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には7.3%の年間複合成長率（CAGR）で130億5,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、バイオシミラーの市場への参入、ヘルスケア政策の変化、費用対効果の重視、研究開発への投資の増加、精密医療と個別化治療の重視に起因すると考えられます。予測期間中に予想される主な動向には、現実世界での証拠の生成、小児集団におけるこれらの医薬品の使用拡大、自己投与薬への移行、価値ベースの価格設定モデルの採用、標的療法の開発などが含まれます。

ヒュミラ医薬品市場は、自己免疫疾患の発症率の上昇により成長が見込まれています。自己免疫疾患には、免疫システムが体内の健康な組織や細胞を攻撃し、損傷を与えることが関係します。ヒュミラは、さまざまな自己免疫疾患によって引き起こされる痛みや炎症の治療に利用される薬剤で、自己免疫疾患の発生率の増加に対応して需要の増加が見込まれています。 2021年7月の時点で、米国に拠点を置く非営利学術医療センターであるクリーブランド・クリニックの統計によると、米国の15人に1人が自己免疫疾患を患っていることが明らかになりました。注目すべきことに、米国では100万人が狼瘡に罹患しており、140万人がクローン病または潰瘍性大腸炎を患っています。この自己免疫疾患の急増により、ヒュミラ医薬品市場が推進されようとしています。

ヒュミラ医薬品市場も、さまざまな国や地域にわたって広範な規制当局の承認が得られたことにより、大幅な成長を遂げています。世界中の政府による規制の承認により、ヒュミラ医薬品の世界のアクセシビリティが強化されています。たとえば、米国食品医薬品局（FDA）は、2021年2月にヒュミラの効能サプリメントを承認し、中等度から重度の活動性潰瘍性大腸炎を患う5歳以上の小児患者の治療の適応を拡大しました。さらに、2023年4月には欧州委員会が承認しました。欧州連合においてバイオシミラーHyrimoz（アダリムマブ）のクエン酸塩を含まない高濃度製剤（HCF）の販売認可を取得しました。 Humiraに対する広範な規制当局の承認は、ヒュミラ医薬品市場の継続的な成長に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のヒュミラ医薬品市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• ヒュミラシリンジ
• ヒュミラペン
• 世界のヒュミラ医薬品市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 強直性脊椎炎
• 関節リウマチ
• クローン病
• その他の用途
• 世界のヒュミラ医薬品市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 病院
• 専門クリニック
• その他のエンドユーザー

第7章 地域および国の分析

• 世界のヒュミラ医薬品市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界のヒュミラ医薬品市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• ヒュミラ医薬品市場の競合情勢
• ヒュミラ医薬品市場の企業プロファイル
  • Pfizer Inc.
  • Merck &Co. Inc.
  • AbbVie Inc.
  • Novartis AG
  • Fresenius Kabi AG

第31章 その他の大手および革新的な企業

• Amgen Inc.
• Boehringer Ingelheim International GmbH
• Viatris Inc.
• Sandoz International GmbH
• Hikma Pharmaceuticals PLC
• Celltrion Healthcare Co. Ltd.
• Cadila Pharmaceuticals Ltd.
• Torrent Pharmaceuticals Ltd.
• Mochida Pharmaceutical Co. Ltd.
• Innovent Biologics Inc.
• Biocad Biopharmaceutical Company
• Shanghai Henlius Biotech Inc.
• Glenmark Pharmaceuticals Ltd.
• Samsung Bioepis Co Ltd.
• Hetero Healthcare Ltd.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Humira, or adalimumab, is an injectable medication prescribed for the treatment of rheumatoid arthritis and other related conditions. These drugs are utilized to alleviate pain and reduce swelling associated with various types of arthritis.

The primary forms of Humira drugs are Humira syringes and Humira pens. Humira syringes are a form of treatment specifically used for progressive rheumatoid arthritis. The diverse applications of Humira include treating conditions such as ankylosing spondylitis, rheumatoid arthritis, Crohn's disease, and others. These drugs are employed by various end-users, including hospitals, specialty clinics, and other healthcare facilities.

The humira drugs market research report is one of a series of new reports from The Business Research Company that provides humira drugs market statistics, including humira drugs industry global market size, regional shares, competitors with a humira drugs market share, detailed humira drugs market segments, market trends, and opportunities, and any further data you may need to thrive in the humira drugs industry. This humira drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The humira drug market size has grown strongly in recent years. It will grow from $9.19 billion in 2023 to $9.86 billion in 2024 at a compound annual growth rate (CAGR) of 7.3%. The growth observed in the historical period can be attributed to factors such as the introduction of biologics, advancements in biotechnology, increasing patient demand for effective treatments, and the adoption and prescribing patterns of physicians.

The humira drug market size is expected to see strong growth in the next few years. It will grow to $13.05 billion in 2028 at a compound annual growth rate (CAGR) of 7.3%. The anticipated growth in the forecast period can be attributed to the entry of biosimilars into the market, changes in healthcare policies, a focus on cost-effectiveness, increased investments in research and development, and the emphasis on precision medicine and personalized treatments. Major trends expected in the forecast period include the generation of real-world evidence, expanded use of these medications in pediatric populations, a shift towards self-administered medications, the adoption of value-based pricing models, and the development of targeted therapies.

The humira drug market is anticipated to experience growth due to a rise in the incidence rate of autoimmune diseases. Autoimmune diseases involve the immune system attacking and damaging healthy tissues and cells in the body. Humira, a drug utilized for treating pain and inflammation caused by various autoimmune diseases, is expected to see increased demand in response to the growing incidence of autoimmune diseases. As of July 2021, statistics from Cleveland Clinics, a US-based non-profit academic medical center, reveal that 1 in 15 people in the U.S. suffer from an autoimmune disease. Notably, one million individuals in the U.S. are affected by lupus, while 1.4 million have Crohn's disease or ulcerative colitis. This surge in autoimmune diseases is poised to propel the HUMIRA drug market.

The humira drug market is also witnessing significant growth due to broad regulatory approvals granted across various countries and regions. Regulatory endorsements by governments worldwide enhance the accessibility of the humira drug globally. For instance, the U.S. Food and Drug Administration (FDA) approved an efficacy supplement for HUMIRA, extending its indication for treating pediatric patients aged 5 and above with moderately to severely active ulcerative colitis in February 2021. Additionally, in April 2023, the European Commission granted marketing authorization for a citrate-free high concentration formulation (HCF) of the biosimilar Hyrimoz (adalimumab) in the European Union. The expansive regulatory approvals for Humira contribute significantly to the ongoing growth of the humira drug market.

Product innovation stands out as a key trend in the humira drug market, with major companies developing new biologics and biosimilars to maintain their market positions. In April 2023, Sandoz, a Switzerland-based pharmaceutical company, introduced the Biosimilar Hyrimoz (adalimumab), featuring a citrate-free high-concentration formulation (HCF) approved by the European Commission. This innovative formulation provides a 50% reduction in injection volume and offers an improved experience for patients with various diseases, including rheumatic diseases and Crohn's disease.

Major companies in the humira drug market are actively focusing on the development of biosimilars for humira drugs. This strategic approach aims to enhance the cost-effectiveness of humira drugs by producing specialty biosimilars tailored for these medications. In October 2023, Boehringer Ingelheim, a Germany-based pharmaceutical company, launched a biosimilar of Humira, approved by the US Food and Drug Administration as interchangeable with the original product, offering a more cost-effective alternative.

In August 2023, CVS Health Corporation, a US-based pharmacy company, entered into a partnership with Sandoz Group AG, a Switzerland-based pharmaceuticals company. This collaboration aims to create a nearly identical drug at a significantly lower cost than the popular arthritis treatment Humira. The partnership establishes Cordavis, a new subsidiary of Novartis, with a primary focus on ensuring the supply of novel biosimilar medications. This strategic move positions CVS Health to compete effectively in the biosimilars market, projected to reach $100 billion in sales over the next six years.

Major companies operating in the humira drug market report are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

North America was the largest region in the humira drug market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the humira drug market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The humira drug market consists of sales of single-dose pen, a single-dose prefilled syringe, and a single-dose vial of liquid solution. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Humira Drug Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on humira drug market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for humira drug ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The humira drug market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Humira Syringe; Humira Pen
• 2) By Application: Ankylosing Spondylitis; Rheumatoid Arthritis; Crohn's Disease; Other Applications
• 3) By End-Users: Hospitals; Specialty Clinics; Other End-Users
• Companies Mentioned: Pfizer Inc.; Merck & Co. Inc.; AbbVie Inc.; Novartis AG; Fresenius Kabi AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Humira Drug Market Characteristics

3. Humira Drug Market Trends And Strategies

4. Humira Drug Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Humira Drug Market Size and Growth

• 5.1. Global Humira Drug Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Humira Drug Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Humira Drug Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Humira Drug Market Segmentation

• 6.1. Global Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Humira Syringe
• Humira Pen
• 6.2. Global Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Ankylosing Spondylitis
• Rheumatoid Arthritis
• Crohn's Disease
• Other Applications
• 6.3. Global Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Specialty Clinics
• Other End-Users

7. Humira Drug Market Regional And Country Analysis

• 7.1. Global Humira Drug Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Humira Drug Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Humira Drug Market

• 8.1. Asia-Pacific Humira Drug Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Humira Drug Market

• 9.1. China Humira Drug Market Overview
• 9.2. China Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Humira Drug Market

• 10.1. India Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Humira Drug Market

• 11.1. Japan Humira Drug Market Overview
• 11.2. Japan Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Humira Drug Market

• 12.1. Australia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Humira Drug Market

• 13.1. Indonesia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Humira Drug Market

• 14.1. South Korea Humira Drug Market Overview
• 14.2. South Korea Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Humira Drug Market

• 15.1. Western Europe Humira Drug Market Overview
• 15.2. Western Europe Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Humira Drug Market

• 16.1. UK Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Humira Drug Market

• 17.1. Germany Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Humira Drug Market

• 18.1. France Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Humira Drug Market

• 19.1. Italy Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Humira Drug Market

• 20.1. Spain Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Humira Drug Market

• 21.1. Eastern Europe Humira Drug Market Overview
• 21.2. Eastern Europe Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Humira Drug Market

• 22.1. Russia Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Humira Drug Market

• 23.1. North America Humira Drug Market Overview
• 23.2. North America Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Humira Drug Market

• 24.1. USA Humira Drug Market Overview
• 24.2. USA Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Humira Drug Market

• 25.1. Canada Humira Drug Market Overview
• 25.2. Canada Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Humira Drug Market

• 26.1. South America Humira Drug Market Overview
• 26.2. South America Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Humira Drug Market

• 27.1. Brazil Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Humira Drug Market

• 28.1. Middle East Humira Drug Market Overview
• 28.2. Middle East Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Humira Drug Market

• 29.1. Africa Humira Drug Market Overview
• 29.2. Africa Humira Drug Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Humira Drug Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Humira Drug Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Humira Drug Market Competitive Landscape And Company Profiles

• 30.1. Humira Drug Market Competitive Landscape
• 30.2. Humira Drug Market Company Profiles
  • 30.2.1. Pfizer Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Merck & Co. Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. AbbVie Inc.
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Novartis AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Fresenius Kabi AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Humira Drug Market Other Major And Innovative Companies

• 31.1. Amgen Inc.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Viatris Inc.
• 31.4. Sandoz International GmbH
• 31.5. Hikma Pharmaceuticals PLC
• 31.6. Celltrion Healthcare Co. Ltd.
• 31.7. Cadila Pharmaceuticals Ltd.
• 31.8. Torrent Pharmaceuticals Ltd.
• 31.9. Mochida Pharmaceutical Co. Ltd.
• 31.10. Innovent Biologics Inc.
• 31.11. Biocad Biopharmaceutical Company
• 31.12. Shanghai Henlius Biotech Inc.
• 31.13. Glenmark Pharmaceuticals Ltd.
• 31.14. Samsung Bioepis Co Ltd.
• 31.15. Hetero Healthcare Ltd.

32. Global Humira Drug Market Competitive Benchmarking

33. Global Humira Drug Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Humira Drug Market

35. Humira Drug Market Future Outlook and Potential Analysis

• 35.1 Humira Drug Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Humira Drug Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Humira Drug Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer